Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd Immunotherapy of Cancer Conference (ITOC3) /
Immunology highlights from the ITOC-3 conference

21st - 23rd Mar 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.04.16
Views: 1677
Rating:

Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria

Prof Zwierzina talks to ecancertv at ITOC-3 about the importance of the conference and the highlights arising from it.

Areas of specific interest from this years conference include recent advances in the use of biomarkers as prognostic indicators, a growing understanding of the therapeutic powers of checkpoint inhibitors and increased efficacy of treatments by utilising combination therapies, curing even metatstatic patients.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation